A prospective multicenter phase II study evaluating multimodality treatment of patients with peritoneal carcinomatosis arising from appendiceal and colorectal cancer: the COMBATAC trial

<p>Abstract</p> <p>Background</p> <p>Peritoneal carcinomatosis is regarded as a common sign of advanced tumor stage, tumor progression or local recurrence of appendiceal and colorectal cancer and is generally associated with poor prognosis. Although survival of patients...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Glockzin Gabriel, Rochon Justine, Arnold Dirk, Lang Sven A, Klebl Frank, Zeman Florian, Koller Michael, Schlitt Hans J, Piso Pompiliu
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BMC 2013-02-01
Sarja:BMC Cancer
Aiheet:
Cytoreductive surgery
HIPEC
Perioperative chemotherapy
Cetuximab
Colorectal cancer
Peritoneal carcinomatosis
Linkit:http://www.biomedcentral.com/1471-2407/13/67
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia